Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (125)
- Compliance and enforcement (33)
- Import and export (30)
- Shortages and supply disruptions (16)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1291 result(s) found, displaying 1201 to 1225
-
Market actions
-
Market actions
-
-
Market actions
-
Market actionsThe company is taking this action as a precaution because of reports of a rare, but serious, eye infection, Acanthamoeba keratitis, caused by a parasite.
-
Market actions
-
Market actions
-
Market actions
-
Market actionsManufacture of the goods has been carried out by a manufacturer while the manufacturer did not hold a current licence, and the goods have been supplied whilst not complying with the applicable standards such as including labelling.
-
Market actionsA connector component used in a previous version of Fisher and Paykel CPAP masks may fail prematurely.
-
Market actionsSpecific lots are being recalled because of production-line problems at AMO's manufacturing plant, which could affect the sterility of the product.
-
Market actionsThe design of the electrical power inlet to the humidifier is faulty.
-
Market actionsPotential that the power pack could shut down the D-TRONplus Insulin Pump without any warning resulting in under-delivery of insulin.
-
Market actionsIncreasing evidence suggesting an association between the product formulation and a rare eye infection (Fusarium keratitis).
-
Safety alertsPhenylpropanolamine is no longer available in Australia due to safety concerns, including the risk of haemorrhagic stroke. Consult your doctor if you have concerns.
-
Market actionsThe products may be contaminated with bacteria and may pose a risk to health.
-
Market actionsThese products may be contaminated with bacteria and may pose a risk to health.
-
Market actions
-
Market actions
-
Safety alertsParoxetine use in early pregnancy may increase the risk of congenital malformations, particularly heart defects, so women planning to become pregnant or in early pregnancy should consult their doctor.
-
Safety alertsSafety review of SSRI antidepressants for pregnant women due to possible infant heart defects.
-
Safety alertsSafety review of SSRI antidepressants for pregnant women due to potential heart defects in infants, especially with paroxetine.
-
Safety alertsGuidant Australia is issuing hazard alert letters to cardiologists on a fault with a limited number of their implantable pacemakers.
-
Market actionsSamples were found to be contaminated with micro-organisms.
-
Safety alertsSome Ayurvedic medicines have been found to contain toxic heavy metals. We're working on improving quality standards.